The ethics of phase I trials of biologic agents
- 1 October 2008
- journal article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Gastroenterology & Hepatology
- Vol. 5 (10), 533
- https://doi.org/10.1038/ncpgasthep1259
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Preventing antibodies to infliximab in patients with Crohn's disease: Optimize not immunizeGastroenterology, 2003
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997